Is little-known hMPV virus the NEW Covid? As bug ravages China and UK faces ‘medium ...
SCENES of crowded hospitals in China have stoked fears of the next Covid, with cases of a little-known winter virus reported to be surging. Human metapneumovirus (hMPV) is the latest bug to bring ...
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), ...
NanoViricides: Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum ...
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are go ...
MyChesCo on MSN3 天
HHS Unleashes $306M to Tackle H5N1 Avian Flu Threat in Unprecedented Preparedness Push
The U.S. Department of Health and Human Services (HHS) has announced a massive $306 million investment toward bolstering ...
Zawya4 天
Uganda conquers Ebola in 69 days
Uganda declared an outbreak of Ebola disease caused by the Sudan ebolavirus (SUDV), with the first confirmed case identified at Mubende Regional Referral Hospital. Over the course of the outbreak, 164 ...
Pharmaceutical Technology4 天
SLV-213 by Selva Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
SLV-213 is under clinical development by Selva Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).